Vomiting

• FDA approval · 2008-10-28
  FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for metoclopramide from ANI Pharmaceuticals, Inc., for an already approved generic product. This…

• FDA approval · 2008-09-08
  FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for Prochlorperazine Maleate from Chartwell RX, LLC, indicating an approved change under an existing…

• FDA approval · 2008-09-03
  FDA Approved: PROCHLORPERAZINE — Supplemental Application (Cosette Pharmaceuticals, Inc.)

  The FDA approved Cosette Pharmaceuticals, Inc.'s supplemental application for Prochlorperazine, a generic antiemetic, under ANDA 040058.

• FDA approval · 2007-12-21
  FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)

  FDA approved a supplemental application for Metoclopramide Hydrochloride (generic) from Chartwell Governmental & Specialty RX, LLC. The acti…

• FDA approval · 2007-06-25
  FDA Approved: ONDANSETRON — Original Application (ACTAVIS PHARMA, INC.)

  FDA approved Actavis's original ANDA for ondansetron tablets, a generic antiemetic. This product is indicated to prevent nausea and vomiting…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2007-01-24
  FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved a supplemental application for metoclopramide from Teva Pharmaceuticals USA, Inc., resulting in changes to the product labe…